MX9200452A - Acidos aril o arilalquil-acil-amino-alquil-hidroxidifosfonicos, un procedimiento para su preparacion y su uso en la terapia de trastornos ostearticulares y del tejido conectivo. - Google Patents

Acidos aril o arilalquil-acil-amino-alquil-hidroxidifosfonicos, un procedimiento para su preparacion y su uso en la terapia de trastornos ostearticulares y del tejido conectivo.

Info

Publication number
MX9200452A
MX9200452A MX9200452A MX9200452A MX9200452A MX 9200452 A MX9200452 A MX 9200452A MX 9200452 A MX9200452 A MX 9200452A MX 9200452 A MX9200452 A MX 9200452A MX 9200452 A MX9200452 A MX 9200452A
Authority
MX
Mexico
Prior art keywords
ostearticular
hydroxidiphosphonic
arilalkyl
acil
aril
Prior art date
Application number
MX9200452A
Other languages
English (en)
Inventor
Sergio Rosini
Maurizio Mian
Original Assignee
Gentili Ist Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gentili Ist Spa filed Critical Gentili Ist Spa
Publication of MX9200452A publication Critical patent/MX9200452A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572Five-membered rings
    • C07F9/5728Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/04Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839Polyphosphonic acids
    • C07F9/3873Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Lubricants (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MX9200452A 1991-02-01 1992-01-31 Acidos aril o arilalquil-acil-amino-alquil-hidroxidifosfonicos, un procedimiento para su preparacion y su uso en la terapia de trastornos ostearticulares y del tejido conectivo. MX9200452A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI910254A IT1244698B (it) 1991-02-01 1991-02-01 Acidi aril-o arilalchil-acil ammino-alchil-idrossidifosfonici, procedimento per la loro preparazione e loro uso in terapia osteo-articolare e dei tessuti connettori in generale

Publications (1)

Publication Number Publication Date
MX9200452A true MX9200452A (es) 1992-08-01

Family

ID=11358376

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9200452A MX9200452A (es) 1991-02-01 1992-01-31 Acidos aril o arilalquil-acil-amino-alquil-hidroxidifosfonicos, un procedimiento para su preparacion y su uso en la terapia de trastornos ostearticulares y del tejido conectivo.

Country Status (20)

Country Link
US (1) US5466682A (es)
EP (1) EP0569411B1 (es)
JP (1) JP3046624B2 (es)
KR (1) KR100190911B1 (es)
AT (1) ATE120464T1 (es)
AU (1) AU653780B2 (es)
CA (1) CA2101548C (es)
CZ (1) CZ288731B6 (es)
DE (1) DE69201863T2 (es)
DK (1) DK0569411T3 (es)
ES (1) ES2069990T3 (es)
FI (1) FI105403B (es)
HK (1) HK1006311A1 (es)
HU (2) HU215918B (es)
IT (1) IT1244698B (es)
MX (1) MX9200452A (es)
PT (1) PT100075B (es)
RU (1) RU2079505C1 (es)
SK (1) SK280053B6 (es)
WO (1) WO1992013864A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6452098A (en) 1997-03-07 1998-09-22 Metabasis Therapeutics, Inc. Novel purine inhibitors of fructose-1,6-bisphosphatase
AU6691798A (en) 1997-03-07 1998-09-22 Metabasis Therapeutics, Inc. Novel indole and azaindole inhibitors of fructose-1,6-bisphosphatase
HUP0300227A2 (hu) * 2003-01-28 2004-09-28 Richter Gedeon Vegyészeti Gyár Rt. Eljárás nagy tisztaságú 2-szubsztituált -1-(hidroxi-etilidén)-1,1-biszfoszfonsavak és sóik előállítására

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2530139C3 (de) * 1975-04-30 1979-06-21 Joh. A. Benckiser Gmbh, 6700 Ludwigshafen N-Acyl-1 -aminoalkan-1,1 -diphosphonsäuren, deren Herstellung und Verwendung
DE2651904C2 (de) * 1976-11-13 1983-01-05 Joh. A. Benckiser Gmbh, 6700 Ludwigshafen Verfahren zur Herstellung von N-Acyl-N-alkylaminomethandiphosphonsäuren
DE3203308A1 (de) * 1982-01-27 1983-07-28 Schering Ag, 1000 Berlin Und 4619 Bergkamen Diphosphonsaeure-derivate und diese enthaltende pharmazeutische praeparate
EP0084822B1 (de) * 1982-01-27 1986-01-08 Schering Aktiengesellschaft Diphosphonsäure-Derivate und diese enthaltende pharmazeutische Präparate
FR2531088B1 (fr) * 1982-07-29 1987-08-28 Sanofi Sa Produits anti-inflammatoires derives de l'acide methylenediphosphonique et leur procede de preparation
DE3512536A1 (de) * 1985-04-06 1986-10-16 Boehringer Mannheim Gmbh, 6800 Mannheim Neue diphosphonsaeure-derivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
EP0243173B1 (en) * 1986-04-24 1991-06-26 Fujisawa Pharmaceutical Co., Ltd. New diphosphonic acid compounds, processes for the preparation thereof and pharmaceutical composition comprising the same
DE3623397A1 (de) * 1986-07-11 1988-01-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
JPH0778024B2 (ja) * 1988-10-14 1995-08-23 藤沢薬品工業株式会社 医薬化合物とジホスホン酸誘導体の結合体を含有する医薬用製剤
PH26923A (en) * 1989-03-08 1992-12-03 Ciba Geigy N-substituted amino alkanediphosphonic acids
US5159108A (en) * 1990-09-18 1992-10-27 Merck & Co., Inc. Process for preparing an antihypercalcemic agent

Also Published As

Publication number Publication date
ITMI910254A1 (it) 1992-08-01
CZ288731B6 (cs) 2001-08-15
IT1244698B (it) 1994-08-08
HUT64964A (en) 1994-03-28
ATE120464T1 (de) 1995-04-15
JP3046624B2 (ja) 2000-05-29
HU215918B (hu) 1999-03-29
EP0569411B1 (en) 1995-03-29
DE69201863D1 (de) 1995-05-04
HU211203A9 (en) 1995-11-28
PT100075A (pt) 1993-03-31
CA2101548A1 (en) 1992-08-02
AU653780B2 (en) 1994-10-13
ITMI910254A0 (it) 1991-02-01
PT100075B (pt) 1999-06-30
FI933231A0 (fi) 1993-07-16
AU1170992A (en) 1992-09-07
HU9302188D0 (en) 1993-10-28
SK79993A3 (en) 1993-12-08
ES2069990T3 (es) 1995-05-16
WO1992013864A1 (en) 1992-08-20
RU2079505C1 (ru) 1997-05-20
SK280053B6 (sk) 1999-07-12
JPH06504783A (ja) 1994-06-02
HK1006311A1 (en) 1999-02-19
EP0569411A1 (en) 1993-11-18
US5466682A (en) 1995-11-14
FI933231A (fi) 1993-07-16
CZ153393A3 (en) 1994-01-19
DE69201863T2 (de) 1995-09-07
KR100190911B1 (ko) 1999-06-01
DK0569411T3 (da) 1995-08-28
CA2101548C (en) 2002-08-27
FI105403B (fi) 2000-08-15

Similar Documents

Publication Publication Date Title
MX9207382A (es) Nuevos compuestos que tienen actividad terapeutica intermediarios para su preparacion, proceso para obtencion de tales compuestos y formulacion farmaceutica que los contiene.
ATE60759T1 (de) Bisdimethoxymethyl(trimethoxybenzyl)isochinolinium salze, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ES491225A0 (es) Procedimiento para la preparacion de 2,4-diamino-pirimidin-5-carbanilidas
IT1248702B (it) Agente antitussivo e mucoregolatore,sua preparazione e composizioni farmaceutiche
ATE184598T1 (de) Enniatine und enniatinderivate zur bekämpfung von endoparasiten
ES529311A0 (es) Un procedimiento para la preparacion de nuevas 1,2,3,4--tetrahidro-2-naftilaminas.
KR960701051A (ko) 이미다조피리딘 및 이를 위장 질환의 치료에 사용하는 방법(imidazopyridines and their use in treating castrointestinal diseases)
KR950031060A (ko) 골다공증 치료용 약제학적 조성물
FI972434A0 (fi) Lamotrigiiniä sisältävä farmaseuttinen koostumus
AU555818B2 (en) Amino hydroxy proprophenones pharmaceutical use
ES2129112T3 (es) Compuestos aromaticos policiclicos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
ES2109509T3 (es) Procedimiento para la preparacion de beta-fenilisoserina y de sus analogos.
ZA879280B (en) Basically substituted phenylacetonitriles,their preparation and drugs containing these compounds
SE8207224L (sv) Nya aromatiska aminoalkoxiderivat, deras framstellning och deras terapeutiska anvendning
MX9200452A (es) Acidos aril o arilalquil-acil-amino-alquil-hidroxidifosfonicos, un procedimiento para su preparacion y su uso en la terapia de trastornos ostearticulares y del tejido conectivo.
ZA90962B (en) Phenylhydrazones,the manufacture thereof and therapeutic and cosmetic compositions prepared therefrom
ES476427A1 (es) Procedimiento para preparar tetrahidro-1,3,5-triazina-2,6- dionas.
ES2072332T3 (es) Derivados de la dibenzo(1,5)dioxocin-5-ona, su uso en medicamentos y procedimiento para su fabricacion.
TW261605B (es)
ATE134363T1 (de) N-((4,5-dihydroxy- und 4,5,8-trihydroxy-9,10- dihydro-9,10-dioxo-2-anthracen- yl)carbonyl)aminosäure zur therapie osteoartikulärer leiden
ES2118255T3 (es) Agente para uso como antiirritante.
ES2074264T3 (es) Esteres de aminoacidos de la hidroquinona, su procedimiento de preparacion y composiciones farmaceuticas o cosmeticas que los contienen.
AR015724A1 (es) La utilizacion de un inhibidor del intercambiador entre na+ y h+ para la preparacion de un medicamento destinado al tratamiento o a la profilaxia deenfermedades del sistema nervioso central.